Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma

Author(s):  
E. M. Kithsiri Wijeratne ◽  
Ya-Ming Xu ◽  
Manping X. Liu ◽  
Marielle C. Inacio ◽  
Alan D. Brooks ◽  
...  
Medicina ◽  
2020 ◽  
Vol 56 (6) ◽  
pp. 318
Author(s):  
Giovanni Cochetti ◽  
Diego Cocca ◽  
Stefania Maddonni ◽  
Alessio Paladini ◽  
Elena Sarti ◽  
...  

With the widespread use of imaging modalities performed for the staging of prostate cancer, the incidental detection of synchronous tumors is increasing in frequency. Robotic surgery represents a technical evolution in the treatment of solid tumors of the urinary tract, and it can be a valid option in the case of multi-organ involvement. We reported a case of synchronous prostate cancer and bifocal renal carcinoma in a 66-year-old male. We performed the first case of a combined upper- and lower-tract robotic surgery for a double-left-partial nephrectomy associated with radical prostatectomy by the transperitoneal approach. A comprehensive literature review in this field has also been carried out. Total operative time was 265 min. Renal hypotension time was 25 min. Blood loss was 250 mL. The patient had an uneventful postoperative course. No recurrence occurred after 12 months. In the literature, 10 cases of robotic, radical, or partial nephrectomy and simultaneous radical prostatectomy have been described. Robotic surgery provides less invasiveness than open surgery with comparable oncological efficacy, overcoming the limitations of the traditional laparoscopy. During robotic combined surgery for synchronous tumors, the planning of the trocars’ positioning is crucial to obtain good surgical results, reducing the abdominal trauma, the convalescence, and the length of hospitalization with a consequent cost reduction. Rare complications can be related to prolonged pneumoperitoneum. Simultaneous robotic prostatectomy and partial nephrectomy appears to be a safe and feasible surgical option in patients with synchronous prostate cancer and renal cell carcinoma.


2016 ◽  
Vol 118 ◽  
pp. 230-243 ◽  
Author(s):  
Marcella Bassetto ◽  
Salvatore Ferla ◽  
Fabrizio Pertusati ◽  
Sahar Kandil ◽  
Andrew D. Westwell ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e16025-e16025
Author(s):  
G. Hruby ◽  
J. Van Batavia ◽  
M. Wosnitzer ◽  
M. Benson ◽  
M. Desai ◽  
...  

e16025 Background: Patients with ESRD on long term hemodialysis are known to be at an increased risk for renal cell carcinoma. We postulate that some component of chronic renal failure not corrected by dialysis might be the tumor-inducing factor. We sought to determine if chronic renal insufficiency is a risk factor for developing renal cell carcinoma. Methods: A case- control study was used to determine a relationship between renal carcinoma and glomerular filtration rate (MDRD) (eGFR) and using patients with prostate cancer as controls. 1,298 patients from the Columbia University Urologic Oncology Database were identified with either prostate or kidney cancer who had sufficient information to predict eGFR. eGFR calculations were performed for both groups. eGFR was divided into two groups based upon the cut-off value of ≥90. eGFR was also categorized according to the MDRD definitions of chronic kidney disease (CKD), CKD1–4 (values≥90, 60≤values<90, 30≤values<60, and values<30, respectively). Logistic regression techniques were used to quantify the association between pre-operative glomerular filtration rate and the presence of renal or prostate cancer. Results: The mean age of the prostate (n=713) and kidney (n=585) group was 59.9 and 61 years, respectively (p=0.041). The mean weight was 83.9 and 87 kg, respectively (p=0.005). The mean serum creatinine was 1.01 and 1.29 mg/dL, respectively (p<0.001). The mean eGFR was 85 and 73.8, respectively (p<0.001). Two models were fit to analyze the association of eGFR. The first model found eGFR <90 was significantly associated with the presence of a renal carcinoma when controlling for age and race (OR=1.93, CI=1.49–2.49). The second model investigated the eGFR-CKD categories while controlling for age and race and was able to predict the presence of renal cancer (p < 0.001). Patients with an eGFR value of 60≤X<90 had an OR of 1.47 (CI= 1.13–1.92) for renal cancer when compared to patients with normal eGFR levels. Patients with an eGFR value of 30≤X<60 and <30 had an OR of 6.26 (CI=4.10–9.55) and 21.11 (CI=4.87–91.42), respectively. Conclusions: Diminished renal function showed a significant association with the presence of renal cancer. Chronic renal insufficiency may be a risk factor for the development of renal carcinoma. No significant financial relationships to disclose.


2017 ◽  
Vol 80 (7) ◽  
pp. 1981-1991 ◽  
Author(s):  
Ya-Ming Xu ◽  
E. M. Kithsiri Wijeratne ◽  
Ashley L. Babyak ◽  
Hanna R. Marks ◽  
Alan D. Brooks ◽  
...  

2020 ◽  
Vol 63 (22) ◽  
pp. 13861-13877
Author(s):  
Subhendu Karmakar ◽  
Hana Kostrhunova ◽  
Tereza Ctvrtlikova ◽  
Vojtech Novohradsky ◽  
Dan Gibson ◽  
...  

2019 ◽  
Vol 39 (7) ◽  
pp. 3835-3845
Author(s):  
MARÍA JULIA CASTRO ◽  
VALERIA PILAR CAREAGA ◽  
PAULA ALEJANDRA SACCA ◽  
MARÍA BELÉN FARAONI ◽  
ANA PAULA MURRAY ◽  
...  

RSC Advances ◽  
2019 ◽  
Vol 9 (58) ◽  
pp. 33794-33799 ◽  
Author(s):  
Huiqing Chen ◽  
Yajing Xing ◽  
Jia Xie ◽  
Jiuqing Xie ◽  
Dong Xing ◽  
...  

A series of novel 3-nitro-4-chromanones were synthesized and their in vitro cytotoxicity was evaluated on castration-resistant prostate cancer cell lines.


2001 ◽  
Vol 120 (5) ◽  
pp. A284-A284
Author(s):  
T BOLIN ◽  
A KNEEBONE ◽  
T LARSSON
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document